Characteristics of inclusion studies
First author (publication year) | Study design | Country | Sample size | Mean age/range | Year | Outcome |
(Cantor et al 2018)13 | Cross-sectional study | Colombia | 1272 | >50 | 2014–2015 | POAG |
(Deb et al 2014)24 | Cross-sectional study | India | 208 | HT No: 55.1±7.1 HTN: 55.5±6.2 | 2010–2012 | POAG |
(Hulsman 2007)25 | Cohort study | Netherlands | 5317 | OAG No: 68.8±8.8 OAG: 73.3±7.3 | 1990–1999 | OAG |
(Ishikawa et al 2011)23 | Cross-sectional study | Japan | 710 | POAG No: 53.4±9.9 POAG: 58.8±10.6 | 2007 | POAG |
(Kawasaki et al 2013)21 | Cohort study | Australia | 2417 | OAG No: 64.1±8.5 OAG: 68.2±8.2 | 2003 | OAG |
(Kim et al 2012)26 | Cross-sectional study | South Korea | 1464 | POAG No: 63.5±11.6 POAG: 68.4±10.1 | 2008 | POAG |
(Kim KE et al 2016)27 | Cross-sectional study | Korean | 13 831 | 55.1±0.2 | 2008–2011 | POAG |
(Kim H-A et al 2016)14 | Cross-sectional study | Korean | 8816 | ≥40 | 2010–2012 | POAG |
(Kyari et al 2016)28 | Case–control study | Nigeria | 13 200 | OAG No: 55.4±12.1 OAG: 66.2±12.3 | 2005–2007 | OAG |
(Memarzadeh et al 2010)11 | Cross-sectional study | American | 6130 | OAG No: 54.4±10.6 OAG: 65.4±11.7 | 2008 | OAG |
(Onakoya et al 2009)15 | Case–control study | Nigeria | 200 | POAG No: 54.7±9.65 POAG: 56.7±12.95 | 2004 | POAG |
(Shakya-Vaidya et al 2013)16 | Case–control study | Nepal | 683 | POAG No: 58.54±14.6 POAG: 58.90±14.72 | 2010–2011 | POAG |
(Suzuki et al 2006)29 | Cross-sectional study | Japan | 2874 | POAG No: 57.8±11.6 POAG: 63.8±12.0, | 2000–2001 | POAG |
(Tham et al 2018)30 | Cross-sectional study | Singapore | 9877 | POAG No: 63.4±10.8 POAG: 58.2±10.1 | 2017 | POAG |
(Topouzis et al 2013)31 | Cross-sectional study | Northern Greece | 1991 | POAG No: 70.35±5.5 POAG: 72.7±6.1 | 1999 | POAG |
(Wang et al 2009)17 | Cross-sectional study | China | 3222 | 60.4±10.0 | 2001–2006 | POAG |
HTN, hypertension; OAG, open-angle glaucoma; POAG, primary open-angle glaucoma.